Clinical Scorecard: Ebola Virus Disease: A Distinctively Difficult Case Among Viral Hemorrhagic Fevers
At a Glance
Category
Detail
Condition
Ebola Virus Disease (EVD), a severe viral hemorrhagic fever caused by Ebola virus (EBOV)
Key Mechanisms
Zoonotic spillover from unknown reservoirs followed by human-to-human transmission; causes coagulopathy, shock, multiorgan failure
Target Population
Humans in endemic and outbreak regions, primarily in Africa
Care Setting
Outbreak and epidemic settings with limited infrastructure; requires advanced supportive clinical care and containment facilities
Key Highlights
EBOV is among the deadliest viral hemorrhagic fevers with case fatality rates often exceeding 50%.
Human-to-human transmission after zoonotic spillover makes containment challenging and poses nosocomial risks.
Despite vaccine and therapeutic development, uncertainties about efficacy and insufficient outbreak infrastructure remain significant challenges.
Guideline-Based Recommendations
Diagnosis
Recognize constitutional symptoms with coagulopathy, shock, and multiorgan failure in suspected cases.
Consider epidemiologic context including recent outbreaks and exposure history.
Management
Provide advanced supportive clinical care tailored to multiorgan failure and hemorrhagic manifestations.
Use approved vaccines and targeted therapeutics where available, acknowledging some uncertainty in efficacy.
Monitoring & Follow-up
Closely monitor for progression of coagulopathy, shock, and organ dysfunction.
Implement strict infection control to prevent nosocomial transmission.
Risks
High risk of human-to-human transmission especially in healthcare settings.
Potential for large-scale outbreaks with significant mortality.
Limited knowledge of animal reservoirs and spillover drivers complicates prevention.
Patient & Prescribing Data
Patients affected during EVD outbreaks primarily in West and Central Africa
Vaccines and therapeutics have been developed and approved over the past decade, but efficacy data remain partially uncertain; supportive care is critical.
Clinical Best Practices
Early identification and isolation of suspected EVD cases to limit transmission.
Use of personal protective equipment and strict infection control protocols in healthcare settings.
Investment in outbreak infrastructure and containment facilities to improve response capacity.
Continued research near outbreak regions to better understand EBOV ecology and improve interventions.
